Physician profile
Alan Limfat
NPI 1437241171
$26,576.12
in general payments reported to CMS, 2019-2025
16 companies · $5,599 in 2025
The $5,599 reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,802 · 2020: $391 · 2021: $1,453 · 2022: $6,229 · 2023: $6,540 · 2024: $563 · 2025: $5,599.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $10K · Food and Beverage: $2,702.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,000.00 |
| Food and Beverage | $2,702.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $23,458.65 | 2019-2025 | Precision 1, Dailies Total1, Total30 |
| Coopervision INC. | $668.23 | 2020-2025 | Myday Contact Lens, Misight Contact Lens, Paragon Crt |
| Johnson & Johnson Vision Care, INC. | $567.51 | 2019-2024 | Acuvue |
| Glaukos Corporation | $532.43 | 2022-2023 | Kxl1b-Ce-Marked Kxlsystem, Kxl System (Refurbished) |
| Lumenis Be INC | $468.34 | 2023 | M22 |
| Bausch & Lomb Americas INC. | $322.24 | 2022-2025 | Infuse, Btod |
| Abb Con-Cise Optical Group LLC | $130.73 | 2019 | |
| Sight Sciences, INC. | $76.71 | 2021 | |
| Optos, INC. | $59.41 | 2020-2021 | |
| Dompe US, INC. | $55.80 | 2022-2025 | Oxervate |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $53.11 | 2019-2021 | |
| Visioneering Technologies, INC. | $50.61 | 2019-2022 | |
| Thea Pharma INC. | $47.68 | 2023 | |
| Abbvie INC. | $41.83 | 2022-2023 | |
| Allergan, INC. | $30.31 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Plexus Optix, INC. | $12.53 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Limfat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.